Analyst upgrades were issued for several companies on June 29, including Alnylam Pharmaceuticals, Plug Power, Palantir Technologies, Citi Trends, and others.
1 report, 1 independent
Updated Jun 29
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst upgrades were issued for several companies on June 29, including Alnylam Pharmaceuticals, Plug Power, Palantir Technologies, Citi Trends, and others.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alnylam Pharmaceuticals
biopharmaceutical company
- AstraZeneca's trial failure has created a competitive advantage for Alnylam Pharmaceuticals, which is leveraging AI in its commercial execution.
- Alnylam Pharmaceuticals, SEC, Truist Financial, and Nasdaq were involved in insider trading disclosures, analyst ratings, and stock trading on June 6, 2026.
-
Plug Power
American company
-
Palantir Technologies
American software and services company, specializing in data analysis